Literature DB >> 19703898

PSGL-1-dependent myeloid leukocyte activation.

Alexander Zarbock1, Helena Müller, Yoshihiro Kuwano, Klaus Ley.   

Abstract

Cell-cell interactions mediating leukocyte recruitment and inflammation are crucial for host defense. Leukocyte recruitment into injured tissue proceeds in a multistep process. The first contact of leukocytes with endothelial cells ("capturing" or "tethering") is mediated by selectins and their counter-receptor P-selectin glyco-protein ligand (PSGL)-1. During capture and rolling, leukocytes collect different inflammatory signals, which can activate various pathways. Integration of these signals leads to leukocyte activation, integrin-mediated arrest, cytoskeleton rearrangement, polarization, and transmigration. PSGL-1 on leukocytes also binds to activated platelets, where P-selectin is expressed at locally high site densities following alpha-granule fusion with the plasma membrane. Here, we review the signaling functions of PSGL-1 and speculate how the different known signaling events might relate to different phases of leukocyte recruitment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703898     DOI: 10.1189/jlb.0209117

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  35 in total

Review 1.  Biomechanics of leukocyte rolling.

Authors:  Prithu Sundd; Maria K Pospieszalska; Luthur Siu-Lun Cheung; Konstantinos Konstantopoulos; Klaus Ley
Journal:  Biorheology       Date:  2011       Impact factor: 1.875

Review 2.  Leukocyte integrin activation and deactivation: novel mechanisms of balancing inflammation.

Authors:  Alexander Zarbock; Tibor Kempf; Kai C Wollert; Dietmar Vestweber
Journal:  J Mol Med (Berl)       Date:  2011-11-19       Impact factor: 4.599

Review 3.  Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow.

Authors:  Alexander Zarbock; Klaus Ley; Rodger P McEver; Andrés Hidalgo
Journal:  Blood       Date:  2011-10-20       Impact factor: 22.113

Review 4.  PSGL-1: A New Player in the Immune Checkpoint Landscape.

Authors:  Roberto Tinoco; Dennis C Otero; Amy A Takahashi; Linda M Bradley
Journal:  Trends Immunol       Date:  2017-03-02       Impact factor: 16.687

Review 5.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

Review 6.  Platelet "first responders" in wound response, cancer, and metastasis.

Authors:  David G Menter; Scott Kopetz; Ernest Hawk; Anil K Sood; Jonathan M Loree; Paolo Gresele; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

7.  Type 1 diabetes predisposes to enhanced gingival leukocyte margination and macromolecule extravasation in vivo.

Authors:  C Sima; K Rhourida; T E Van Dyke; R Gyurko
Journal:  J Periodontal Res       Date:  2010-12       Impact factor: 4.419

8.  Targeting the PSGL-1 pathway for immune modulation.

Authors:  Roberto Tinoco; Linda M Bradley
Journal:  Immunotherapy       Date:  2017-09       Impact factor: 4.196

Review 9.  Neutrophil rolling at high shear: flattening, catch bond behavior, tethers and slings.

Authors:  Prithu Sundd; Maria K Pospieszalska; Klaus Ley
Journal:  Mol Immunol       Date:  2012-11-09       Impact factor: 4.407

Review 10.  Platelets as cellular effectors of inflammation in vascular diseases.

Authors:  Matthew T Rondina; Andrew S Weyrich; Guy A Zimmerman
Journal:  Circ Res       Date:  2013-05-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.